The estimated Net Worth of Ernest Orticerio is at least $1.08 Milhão dollars as of 9 January 2019. Ernest Orticerio owns over 20,000 units of Quanterix Corp stock worth over $589,040 and over the last 7 years Ernest sold QTRX stock worth over $487,250.
Ernest has made over 6 trades of the Quanterix Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently Ernest exercised 20,000 units of QTRX stock worth $57,800 on 9 January 2019.
The largest trade Ernest's ever made was exercising 46,671 units of Quanterix Corp stock on 13 December 2017 worth over $106,410. On average, Ernest trades about 20,953 units every 56 days since 2017. As of 9 January 2019 Ernest still owns at least 48,802 units of Quanterix Corp stock.
You can see the complete history of Ernest Orticerio stock trades at the bottom of the page.
Ernest's mailing address filed with the SEC is C/O QUANTERIX CORPORATION,, 113 HARTWELL AVENUE, LEXINGTON, MA, 02421.
Over the last 7 years, insiders at Quanterix Corp have traded over $25,118,881 worth of Quanterix Corp stock and bought 1,481,095 units worth $18,701,541 . The most active insiders traders include David R Walt, Paul M Meister, eKeith Crandell. On average, Quanterix Corp executives and independent directors trade stock every 7 days with the average trade being worth of $100,483. The most recent stock trade was executed by Masoud Toloue on 13 August 2024, trading 19,000 units of QTRX stock currently worth $207,100.
quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).
Quanterix Corp executives and other stock owners filed with the SEC include: